Cortisol suppression and hearing thresholds in tinnitus after low-dose dexamethasone challenge

BMC Ear, Nose and Throat Disorders

Volumn 12, Issue 1, 2012, Pages

  Simoens, Veerle L ^a,b,c   Hébert, Sylvie ^c,d,e  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF JYVÄSKYLÄ   (Finland)

^c BRAMS   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e CENTRE DE RECHERCHE   (Canada)

Author keywords

Cortisol; Hearing sensitivity; Hearing threshold; HPA axis; Low dose dexamethasone suppression test; Stress; Tinnitus

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE;

ACOUSTIC STRESS; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; AUDITORY THRESHOLD; BECK DEPRESSION INVENTORY; BODY MASS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEXAMETHASONE SUPPRESSION TEST; DISEASE DURATION; DRUG EFFICACY; EDUCATIONAL STATUS; FEMALE; HEALTH STATUS; HEARING LOSS; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LOW DRUG DOSE; MALE; TINNITUS;

EID: 84859804967     PISSN: None     EISSN: 14726815     Source Type: Journal    
DOI: 10.1186/1472-6815-12-4     Document Type: Article

References (58)

1. The additive effect of co-occurring anxiety and depression on health status, quality of life and coping strategies in help-seeking tinnitus sufferers. Bartels H, Middel BL, van der Laan BF, Staal MJ, Albers FW, Ear Hear 2008 29 6 947 956 10.1097/AUD.0b013e3181888f83 18941410
2. Tinnitus severity, depression, and the big five personality traits. Langguth B, Kleinjung T, Fischer B, Hajak G, Eichhammer P, Sand PG, Prog Brain Res 2007 166 221 225 17956786 (Pubitemid 47588070)
3. The role of anxiety sensitivity and behavioral avoidance in tinnitus disability. Hesser H, Andersson G, Int J Audiol 2009 48 5 295 299 10.1080/14992020802635325 19842804
4. Tinnitus and depression. Langguth B, Landgrebe M, Kleinjung T, Sand PG, Hajak G, The World Journal of Biological Psychiatry
5. Polysomnographic and quantitative electroencephalographic correlates of subjective sleep complaints in chronic tinnitus. Hebert S, Fullum S, Carrier J, J Sleep Res 2011 20 1 Pt 1 38 44 20561177
6. Prevalence and characteristics of tinnitus among US adults. Shargorodsky J, Curhan GC, Farwell WR, Am J Med 2010 123 8 711 718 10.1016/j.amjmed.2010.02. 015 20670725
7. The neuroscience of tinnitus. Eggermont JJ, Roberts LE, Trends Neurosci 2004 27 11 676 682 10.1016/j.tins.2004.08.010 15474168 (Pubitemid 39335838)
8. The effect of tightened hearing protection regulations on military noise-induced tinnitus. Mrena R, Savolainen S, Kiukaanniemi H, Ylikoski J, Makitie AA, Int J Audiol 2009 48 6 394 400 10.1080/14992020902777225 19925346
9. Otologic and audiologic lesions due to blast injury. Nageris BI, Attias J, Shemesh R, J Basic Clin Physiol Pharmacol 2008 19 3-4 185 191 19025030
10. Change in prevalence of hearing loss in US adolescents. Shargorodsky J, Curhan SG, Curhan GC, Eavey R, Jama 2010 304 7 772 778 10.1001/jama.2010.1124 20716740
11. Predictive factors for the severity of tinnitus. Holgers KM, Erlandsson SI, Barrenas ML, Audiology 2000 39 5 284 291 10.3109/00206090009073093 11093613
12. Emotional exhaustion as a predictor of tinnitus prevalence and severity. Hébert S, Canlon B, Hasson D, Psychotherapy and Psychosomatics
13. Tinnitus handbook. San Diego: Singular, Tyler RS, 2000
14. Stress and prevalence of hearing problems in the Swedish working population. Hasson D, Theorell T, Wallen MB, Leineweber C, Canlon B, BMC Publ Health 2011 11 130 10.1186/1471-2458-11-130
15. Prevalence and characteristics of hearing problems in a working and non-working Swedish population. Hasson D, Theorell T, Westerlund H, Canlon B, J Epidemiology Community Health 2010 64 5 453 460 10.1136/jech.2009.095430
16. The functional neuroanatomy of tinnitus: evidence for limbic system links and neural plasticity. Lockwood AH, Salvi RJ, Coad ML, Towsley ML, Wack DS, Murphy BW, Neurology 1998 50 1 114 120 9443467
17. The neural correlates of tinnitus-related distress. Vanneste S, Plazier M, van der Loo E, Van de Heyning P, Congedo M, De Ridder D, NeuroImage 2010 52 2 470 480 10.1016/j.neuroimage.2010.04.029 20417285
18. Dysregulation of limbic and auditory networks in tinnitus. Leaver AM, Renier L, Chevillet MA, Morgan S, Kim HJ, Rauschecker JP, Neuron 2011 69 1 33 43 10.1016/j.neuron.2010.12.002 21220097
19. Structural brain changes in tinnitus. Muhlau M, Rauschecker JP, Oestreicher E, Gaser C, Rottinger M, Wohlschlager AM, Simon F, Etgen T, Conrad B, Sander D, Cereb Cortex 2006 16 9 1283 1288 16280464 (Pubitemid 44289101)
20. Structural brain changes in tinnitus: grey matter decrease in auditory and non-auditory brain areas. Landgrebe M, Langguth B, Rosengarth K, Braun S, Koch A, Kleinjung T, May A, de Ridder D, Hajak G, NeuroImage 2009 46 1 213 218 10.1016/j.neuroimage.2009.01.069 19413945
21. A physiological correlate for the intolerance to both internal and external sounds. Hebert S, Paiement P, Lupien SJ, Hear Res 2004 190 1-2 1 9 10.1016/S0378-5955(04)00021-8 15051125 (Pubitemid 38404290)
22. Physiological and psychological stress reactivity in chronic tinnitus. Heinecke K, Weise C, Schwarz K, Rief W, J Behav Med 2008 31 3 179 188 10.1007/s10865-007-9145-0 18193350
23. The sound of stress: blunted cortisol reactivity to psychosocial stress in tinnitus sufferers. Hebert S, Lupien SJ, Neurosci Lett 2007 411 2 138 142 10.1016/j.neulet.2006.10.028 17084027 (Pubitemid 44820681)
24. The 'Trier Social Stress Test'-a tool for investigating psychobiological stress responses in a laboratory setting. Kirschbaum C, Pirke KM, Hellhammer DH, Neuropsychobiology 1993 28 1-2 76 81 10.1159/000119004 8255414 (Pubitemid 23283755)
25. The neuroendocrinology of chronic fatigue syndrome. Cleare AJ, Endocr Rev 2003 24 2 236 252 12700181 (Pubitemid 36515286)
26. Corticosteroid receptors and HPA-axis regulation. de Kloet ER, Schmidt M, Meijer OC, Handbook of stress and the brain Amsterdam: Elsevier, Steckler T, Kalin N, Reul J, 2005 15 265 294
27. Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. Ueda K, Okamura N, Hirai M, Tanigawara Y, Saeki T, Kioka N, Komano T, Hori R, J Biol Chem 1992 267 34 24248 24252 1360010
28. Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. Schinkel AH, Wagenaar E, van Deemter L, Mol CA, Borst P, J Clin Invest 1995 96 4 1698 1705 10.1172/JCI118214 7560060
29. Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice. Meijer OC, de Lange EC, Breimer DD, de Boer AG, Workel JO, de Kloet ER, Endocrinology 1998 139 4 1789 1793 10.1210/en.139.4.1789 9528963 (Pubitemid 28513838)
30. The site of the suppressive action of dexamethasone on pituitary-adrenal activity. de Kloet ER, van der Vies J, de Wied D, Endocrinology 1974 94 1 61 73 10.1210/endo-94-1-61 4808893
31. Adrenal steroid receptor activation in rat brain and pituitary following dexamethasone: implications for the dexamethasone suppression test. Miller AH, Spencer RL, Pulera M, Kang S, McEwen BS, Stein M, Biol Psychiatry 1992 32 10 850 869 10.1016/0006-3223(92)90175-Y 1334712 (Pubitemid 23024898)
32. Dexamethasone suppression of corticosteroid secretion: evaluation of the site of action by receptor measures and functional studies. Cole MA, Kim PJ, Kalman BA, Spencer RL, Psychoneuroendocrinology 2000 25 2 151 167 10.1016/S0306-4530(99)00045-1 10674279 (Pubitemid 29525388)
33. The corticosteroid receptor hypothesis of depression. Holsboer F, Neuropsychopharmacology 2000 23 5 477 501 10.1016/S0893-133X(00)00159-7 11027914
34. Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. Yehuda R, Southwick SM, Krystal JH, Bremner D, Charney DS, Mason JW, Am J Psychiatry 1993 150 1 83 86 8417586 (Pubitemid 23059168)
35. Receptors for glucocorticoids in the human inner ear. Rarey KE, Curtis LM, Otolaryngol Head Neck Surg 1996 115 1 38 41 10.1016/S0194-5998(96)70133-X 8758627 (Pubitemid 26292360)
36. Auditory detection and perception in normal man and in patients with adrenal cortical insufficiency: effect of adrenal cortical steroids. Henkin RI, Daly RL, J Clin Invest 1968 47 6 1269 1280 10.1172/JCI105819 4298249
37. Enhanced cochlear acoustic sensitivity and susceptibility to endotoxin are induced by adrenalectomy and reversed by corticosterone supplementation in rat. Siaud P, Maurel D, Lucciano M, Kosa E, Cazals Y, Eur J Neurosci 2006 24 12 3365 3371 10.1111/j.1460-9568.2006.05224.x 17229085 (Pubitemid 44952602)
38. Hydrocortisone reduces auditory sensitivity at high tonal frequencies in adult males. Beckwith BE, Lerud K, Antes JR, Reynolds BW, Pharmacol Biochem Behav 1983 19 3 431 433 10.1016/0091-3057(83)90115-6 6634894 (Pubitemid 13016740)
39. Stress induces transient auditory hypersensitivity in rats. Mazurek B, Haupt H, Joachim R, Klapp BF, ver T, Szczepek AJ, Hear Res 2010 259 1-2 55 63 10.1016/j.heares.2009.10.006 19840840
40. Assessment and amelioration of hyperacusis in tinnitus patients. Dauman R, Bouscau-Faure F, Acta Otolaryngol 2005 125 5 503 509 16092541 (Pubitemid 40676891)
41. Beck AT, Beck Depression Inventory II Toronto, ON: The Psychological Corporation 1997
42. Tinnitus reaction questionnaire: psychometric properties of a measure of distress associated with tinnitus. Wilson PH, Henry J, Bowen M, Haralambous G, J Speech Hear Res 1991 34 1 197 201 2008074
43. Loudness growth in 1/2-octave bands (LGOB)-a procedure for the assessment of loudness. Allen JB, Hall JL, Jeng PS, J Acoust Soc Am 1990 88 2 745 753 10.1121/1.399778 2212299 (Pubitemid 20289773)
44. Individual differences in the diurnal cycle of cortisol. Smyth JM, Ockenfels MC, Gorin AA, Catley D, Porter LS, Kirschbaum C, Hellhammer DH, Stone AA, Psychoneuroendocrinology 1997 22 2 89 105 10.1016/S0306-4530(96)00039-X 9149331 (Pubitemid 27236732)
45. Low-dose dexamethasone suppression test in chronic fatigue syndrome and health. Gaab J, Huster D, Peisen R, Engert V, Schad T, Schurmeyer TH, Ehlert U, Psychosom Med 2002 64 2 311 318 11914448 (Pubitemid 34260470)
46. Combined dexamethasone/corticotropin-releasing factor test in chronic fatigue syndrome. Van Den Eede F, Moorkens G, Hulstijn W, Van Houdenhove B, Cosyns P, Sabbe BGC, Claes SJ, Psychol Med 2008 38 7 963 973 17803834
47. Glucocorticoid receptor mediated negative feedback in chronic fatigue syndrome using the low dose (0.5 mg) dexamethasone suppression test. Papadopoulos A, Ebrecht M, Roberts ADL, Poon L, Rohleder N, Cleare AJ, J Affective Disorders 2009 112 1-3 289 294 10.1016/j.jad.2008.05.001
48. Burnout, perceived stress, and cortisol responses to awakening. Pruessner JC, Hellhammer DH, Kirschbaum C, Psychosom Med 1999 61 2 197 204 10204973 (Pubitemid 29168650)
49. Tinnitus in the General Population With a Focus on Noise and Stress: A Public Health Study. Baigi A, Odens A, Almlid-Larsen V, Barrenas ML, Holgers KM, Ear Hear
50. Dose-dependent pharmacokinetics of dexamethasone. Loew D, Schuster O, Graul EH, Eur J Clin Pharmacol 1986 30 2 225 230 10.1007/BF00614309 3709651 (Pubitemid 16166075)
51. Glucocorticoid receptors modulate auditory sensitivity to acoustic trauma. Canlon B, Meltser I, Johansson P, Tahera Y, Hear Res 2007 226 1-2 61 69 10.1016/j.heares.2006.05.009 16843624 (Pubitemid 46428025)
52. NF-kappaB mediated glucocorticoid response in the inner ear after acoustic trauma. Tahera Y, Meltser I, Johansson P, Bian Z, Stierna P, Hansson AC, Canlon B, J Neurosci Res 2006 83 6 1066 1076 10.1002/jnr.20795 16493680
53. Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder. Yehuda R, Boisoneau D, Lowy MT, Giller EL, Arch Gen Psychiatry 1995 52 7 583 593 10.1001/archpsyc.1995.03950190065010 7598635
54. Tuning out the noise: limbic-auditory interactions in tinnitus. Rauschecker JP, Leaver AM, Mühlau M, Neuron 2010 66 6 819 826 10.1016/j.neuron.2010.04.032 20620868
55. High-frequency tinnitus without hearing loss does not mean absence of deafferentation. Weisz N, Hartmann T, Dohrmann K, Schlee W, Norena A, Hear Res 2006 222 1-2 108 114 10.1016/j.heares.2006.09.003 17079102 (Pubitemid 44708559)
56. Does hypothalamic-pituitary-adrenal axis hypofunction in chronic fatigue syndrome reflect a 'crash' in the stress system? Van Houdenhove B, Van Den Eede F, Luyten P, Medical Hypotheses 2009 72 6 701 705 10.1016/j.mehy.2008.11.044 19237251
57. Emerging pharmacotherapy of tinnitus. Langguth B, Salvi R, Elgoyhen AB, Expert Opin Emerg Drugs 2009 14 4 687 702 10.1517/14728210903206975 19712015
58. Model-based therapeutic correction of hypothalamic-pituitary-adrenal axis dysfunction. Ben-Zvi A, Vernon SD, Broderick G, PLoS Computational Biology 2009 5 1 1000273 10.1371/journal.pcbi.1000273 19165314